Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04635995
Status:
RECRUITING
Last Update Posted:
2023-06-23
First Post:
2020-11-09
Brief Title:
Phase 1 Trial of LVGN7409 CD40 Agonist Antibody as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Sponsor:
Lyvgen Biopharma Holdings Limited
Organization:
Lyvgen Biopharma Holdings Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-09
First Submit QC Date:
November 14 2020
Study First Post Date:
2020-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-22
Last Update Post Date:
2023-06-23
Last Update Post Date Type:
ACTUAL